SHShakir Hussain

Shakir Hussain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shakir Hussain has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Breaking Down the Hierarchy: A New Approach to Leukemia Classification

    by Ibraheem Hamdi, Hosam El-Gendy, Ahmed Sharshar, Mohamed Saeed, Muhammad Ridzuan, Shahrukh K. Hashmi, Naveed Syed, Imran Mirza, Shakir Hussain, Amira Mahmoud Abdalla, et al.

    The complexities inherent to leukemia, multifaceted cancer affecting white blood cells, pose considerable diagnostic and treatment challenges, primarily due to reliance on laborious morphological analyses and expert judgment that are susceptible to errors. Addressing these challenges, this study presents a refined, comprehensive strategy leveraging advanced deep-learning techniques for the classification of leukemia subtypes. We commence by developing a hierarchical label taxonomy, paving the way for differentiating between various subtypes of leukemia. The research further introduces a novel hierarchical approach inspired by clinical procedures capable of accurately classifying diverse types of leukemia alongside reactive and healthy cells. An integral part of this study involves a meticulous examination of the performance of Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) as classifiers. The proposed method exhibits an impressive success rate, achieving approximately 90\% accuracy across all leukemia subtypes, as substantiated by our experimental results. A visual representation of the experimental findings is provided to enhance the model's explainability and aid in understanding the classification process.

  • Open Access

    Elevated Graft-versus-Host Disease Risk Among International Stem Cell Transplant Recipients: A Pilot Study from the UAE

    by Syed Naveed, Afrooz Imrana, Mir Ahmed Farooq, Khan Ali Azmat, Abdulla J.M.H Nada, Hussain Shakir, Chandani Uttam Ashok, Hasan Amera, Samad Abdel Hanin, ElGhazali Gehad, et al.

    Patients from regions without stem cell transplant (SCT) facilities often seek treatment abroad and return home for post-transplant care. While extensive data exists on GVHD and its risk factors, the prevalence of GVHD in international SCT patients returning to countries without transplant facilities, where multiple factors compromise post-transplant care, is not well documented. We screened 149 transplant recipients and analyzed data from 91 who received transplants abroad and were followed at our center from January 2019 to December 2022. This observational study used data from electronic medical records (EMR) and employed descriptive statistics, inferential tests, and relative risk calculations with forest plots to analyze GVHD prevalence and key risk factors. Of the recipients, 31.8% were residents from nine countries living in the UAE, and 67.2% were UAE citizens. Adults comprised 48.3% of the recipients, and 51.7% were pediatric. Hematological malignancies were the most common indication (49%), primarily in adults. Siblings were the majority of donors (52.6%), followed by related donors (23.09%), and unrelated donors (8.9%). Most (69.2%) received HLA-identical transplants followed by 21.9% who received haploidentical. Among adults, 62.2% developed GVHD, compared to 26% of pediatric patients. Recipients with related HLA-identical donors had a 50% GVHD prevalence, while those with unrelated identical donors had 71%. The overall GVHD prevalence was 50% among the 87.9% who received allogeneic SCTs. Despite favorable factors, GVHD prevalence remains high. Larger multicenter studies are needed to identify and assess the impact of contributing factors.

  • Breaking down the Hierarchy: A New Approach to Leukemia Classification

    by Ibraheem Hamdi, Hosam El-Gendy, Ahmed Sharshar, Mohamed Saeed, Muhammad Ridzuan, Shahrukh K. Hashmi, Naveed Syed, Imran Mirza, Shakir Hussain, Amira Mahmoud Abdalla, et al.